Latest BioNTech News & Updates

See the latest news and media coverage for BioNTech. We track all announcements, press releases, and industry mentions in real time, all in one place.

BioNTech

Biotechnology company developing immunotherapies and vaccines

biontech.com

Headquarters: Mainz, Germany
Founded year: 2008
Company type: Private company
Number of employees: 1,000–5,500
Industry: Pharmaceuticals

Last updated Today

Latest news about BioNTech

In short: BioNTech named a new CEO, cut COVID-19 revenue guidance, closed German sites, and posted strong lung cancer data amid trial halts.

Company announcements

September 14 BioNTech

BioNTech reports gotistobart nearly doubled survival in lung cancer trial

Gotistobart showed a median overall survival of 18.5 months versus 10.0 months with chemotherapy in previously treated squamous NSCLC patients.

August 27 BioNTech

BioNTech and Pfizer secure FDA approval for an XFG-targeted COVID-19 vaccine

The approved COMIRNATY XFG formula aligns with current circulating variants and ships immediately to pharmacies for high-risk adults.

August 27 BioNTech

BioNTech divests JPT Peptide Technologies to support manufacturing consolidation plans

The transaction with DUBAG Group concludes this restructuring phase. BioNTech continues evaluating sales for additional facilities through September.

August 20 BioNTech

BioNTech presents new lung cancer pipeline data at WCLC 2026

The announcement highlights first global data for a pumitamig combination therapy and updated survival results across multiple ongoing Phase 3 trials.

Media coverage

September 28 Seeking Alpha

Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits (PFE:NYSE)

Delaware judge lets Monsanto’s mRNA patent lawsuits vs Pfizer, BioNTech, and Moderna proceed. Read m...

September 27 DIE ZEIT

Pharma: Biontech closes Tübingen plant - Palmer: Jobs to be retained

Here you can find information on the topic "Pharma". Read now "Biontech closes Tübingen plant - Palmer: Jobs to be retained".

September 25 Reuters

BioNTech to shutter three sites in Germany as no buyers emerge

German COVID‑19 vaccine maker BioNTech said on Monday that ‌it would close German sites that it has...

September 25 Handelsblatt

Morning Briefing: Biontech, Curevac - and the state's balance sheet as an entrepreneur

The Mainz company closes three coastal towns and lays off 1,800 employees. Particularly in focus: The Tübingen plant. Also because hundreds of millions of taxpayer money were burned there.

Never miss news about BioNTech

Track BioNTech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BioNTech competitors & trending companies

Browse news for competitors to BioNTech and other trending companies.